PharmaBiome

PharmaBiome

Private
SchlierenHealthcare & Life Scienceshttps://www.pharmabiome.com/

Last Round

Seed

Jul 8, 2020

Total Funding Raised

$2.45M

Company Overview

PharmaBiome is a biotechnology company that develops a drug development platform for targeted microbiome therapeutics to treat diseases caused by functional deficiencies in the microbiome.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

live biotherapeutic productsLBPsmicrobiome therapeuticsgut microbiomebacterial consortiapre-clinical biotechco-cultivation technologyrationally designed therapeuticspharmaceutical licensingbug-as-druginflammatory bowel diseaseIBDmicrobiome engineeringdrug discovery platformbiomanufacturinggastroenterology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmaBiome Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

PharmaBiome Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJul 8, 2020
GrantApr 23, 2020
AcceleratorJan 16, 2020
GrantMay 22, 2019
GrantDec 1, 2017
Grant
Jun 14, 2016

Key People

Founding team and executive leadership

Tomas de Wouters

Co-founder, CEO

Founding Team

PharmaBiome Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2025

    Monthly visitors grew 31% MoM, reaching 1K.

  • Dec 17, 2024

    Monthly visitors increased 53% MoM.

PharmaBiome Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharmaBiome Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharmaBiome's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren
Employee Range11
Year Founded2015
Last FundingJul 8, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.